Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2023 · 10-Q
Revenue$7.87M$7.87M+2.5% vs Q3 2022 Net Income$680.56K$680.56K+45.8% vs Q3 2022 EPS Diluted$0.08$0.08+33.3% vs Q3 2022 Operating Income$1,161,044+21.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,348,599N/M Margins · derivedOperating margin14.8%+2.3 pt vs Q3 2022
Net margin8.6%+2.6 pt vs Q3 2022
ended Aug 31, 2023 · filed Oct 12, 2023 · 42 d after period end